MedTrace Logo

Safety and Effectiveness Clinical Evaluation of Injectable Medical Devices

NCT06142578 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2025-04-25

Study results available
· View outcomes & findings →

Summary

The study aims to confirm the safety and effectiveness of FILLGEL devices

Conditions

  • Aesthetic Dermatology

Interventions

DEVICE

Dermal Filler Device

Injection of device by investigators according to the Instruction For Use (IFU)

Sponsors & Collaborators

  • Eurofins Dermscan Pharmascan

    collaborator INDUSTRY

  • Kylane Laboratoires

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-14
Primary Completion
2023-01-12
Completion
2024-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06142578 on ClinicalTrials.gov